These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 27383586)

  • 21. A sound-driven cortical phase-locking change in the Fmr1 KO mouse requires Fmr1 deletion in a subpopulation of brainstem neurons.
    Holley AJ; Shedd A; Boggs A; Lovelace J; Erickson C; Gross C; Jankovic M; Razak K; Huber K; Gibson JR
    Neurobiol Dis; 2022 Aug; 170():105767. PubMed ID: 35588990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.
    Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC
    Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium-Dependent Regulation of Neuronal Excitability Is Rescued in Fragile X Syndrome by a Tat-Conjugated N-Terminal Fragment of FMRP.
    Zhan X; Asmara H; Pfaffinger P; Turner RW
    J Neurosci; 2024 May; 44(21):. PubMed ID: 38664011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astroglial FMRP deficiency cell-autonomously up-regulates miR-128 and disrupts developmental astroglial mGluR5 signaling.
    Men Y; Ye L; Risgaard RD; Promes V; Zhao X; Paukert M; Yang Y
    Proc Natl Acad Sci U S A; 2020 Oct; 117(40):25092-25103. PubMed ID: 32958647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.
    Zhang L; Alger BE
    J Neurosci; 2010 Apr; 30(16):5724-9. PubMed ID: 20410124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNAs and Fragile X Syndrome.
    Lin SL
    Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STEP inhibition reverses behavioral, electrophysiologic, and synaptic abnormalities in Fmr1 KO mice.
    Chatterjee M; Kurup PK; Lundbye CJ; Hugger Toft AK; Kwon J; Benedict J; Kamceva M; Banke TG; Lombroso PJ
    Neuropharmacology; 2018 Jan; 128():43-53. PubMed ID: 28943283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent role for presynaptic FMRP revealed by an FMR1 missense mutation associated with intellectual disability and seizures.
    Myrick LK; Deng PY; Hashimoto H; Oh YM; Cho Y; Poidevin MJ; Suhl JA; Visootsak J; Cavalli V; Jin P; Cheng X; Warren ST; Klyachko VA
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):949-56. PubMed ID: 25561520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astrocyte-mediated disruption of ROS homeostasis in Fragile X mouse model.
    Vandenberg GG; Dawson NJ; Head A; Scott GR; Scott AL
    Neurochem Int; 2021 Jun; 146():105036. PubMed ID: 33785420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astroglial Kir4.1 potassium channel deficit drives neuronal hyperexcitability and behavioral defects in Fragile X syndrome mouse model.
    Bataveljic D; Pivonkova H; de Concini V; Hébert B; Ezan P; Briault S; Bemelmans AP; Pichon J; Menuet A; Rouach N
    Nat Commun; 2024 Apr; 15(1):3583. PubMed ID: 38678030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulated Purinergic Signalling in Fragile X Syndrome Cortical Astrocytes.
    Reynolds KE; Napier M; Fei F; Green K; Scott AL
    Neuromolecular Med; 2024 Sep; 26(1):36. PubMed ID: 39254908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.
    Gross C; Nakamoto M; Yao X; Chan CB; Yim SY; Ye K; Warren ST; Bassell GJ
    J Neurosci; 2010 Aug; 30(32):10624-38. PubMed ID: 20702695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astrocyte-mediated purinergic signaling is upregulated in a mouse model of Fragile X syndrome.
    Reynolds KE; Wong CR; Scott AL
    Glia; 2021 Jul; 69(7):1816-1832. PubMed ID: 33754385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of GpI mGluR-Dependent Cav2.3 Translation in a Mouse Model of Fragile X Syndrome.
    Gray EE; Murphy JG; Liu Y; Trang I; Tabor GT; Lin L; Hoffman DA
    J Neurosci; 2019 Sep; 39(38):7453-7464. PubMed ID: 31350260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hippocampal proteome comparison of infant and adult Fmr1 deficiency mice reveals adult-related changes associated with postsynaptic density.
    Yang C; Huang YT; Yao YF; Fu JY; Long YS
    J Proteomics; 2024 Jul; 303():105202. PubMed ID: 38797434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postsynaptic FMRP promotes the pruning of cell-to-cell connections among pyramidal neurons in the L5A neocortical network.
    Patel AB; Loerwald KW; Huber KM; Gibson JR
    J Neurosci; 2014 Feb; 34(9):3413-8. PubMed ID: 24573297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
    Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
    PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced phenotypic severity following adeno-associated virus-mediated Fmr1 gene delivery in fragile X mice.
    Gholizadeh S; Arsenault J; Xuan IC; Pacey LK; Hampson DR
    Neuropsychopharmacology; 2014 Dec; 39(13):3100-11. PubMed ID: 24998620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interregulation between fragile X mental retardation protein and methyl CpG binding protein 2 in the mouse posterior cerebral cortex.
    Arsenault J; Hooper AWM; Gholizadeh S; Kong T; Pacey LK; Koxhioni E; Niibori Y; Eubanks JH; Wang LY; Hampson DR
    Hum Mol Genet; 2021 Feb; 29(23):3744-3756. PubMed ID: 33084871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of GABAergic Inputs Is Not Altered in Early Maturation of Adult Born Dentate Granule Neurons in Fragile X Mice.
    Remmers CL; Contractor A
    eNeuro; 2018; 5(6):. PubMed ID: 30627633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.